Free Trial

Synthomer (LON:SYNT) Trading Down 20.1% on Analyst Downgrade

Synthomer logo with Basic Materials background

Key Points

  • Synthomer plc shares dropped 20.1% during trading, closing at GBX 63 ($0.84) after reaching a low of GBX 62 ($0.82), with trading volume surging 730% above its average.
  • Analysts have adjusted their ratings and price targets, with Deutsche Bank lowering its target from GBX 140 to GBX 115 and Jefferies maintaining a target of GBX 100.
  • Insiders Janet E. Ashdown and Lily Liu acquired shares at prices around GBX 99 and GBX 64, respectively, contributing to insiders owning 28% of the company's stock.
  • Looking to Export and Analyze Synthomer Data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Synthomer plc (LON:SYNT - Get Free Report)'s stock price was down 20.1% during trading on Wednesday after Berenberg Bank lowered their price target on the stock from GBX 120 to GBX 80. Berenberg Bank currently has a hold rating on the stock. Synthomer traded as low as GBX 62 ($0.83) and last traded at GBX 63 ($0.85). Approximately 6,089,601 shares traded hands during trading, an increase of 730% from the average daily volume of 733,974 shares. The stock had previously closed at GBX 78.80 ($1.06).

Other equities research analysts have also issued reports about the company. Deutsche Bank Aktiengesellschaft dropped their target price on Synthomer from GBX 140 ($1.88) to GBX 115 ($1.55) and set a "hold" rating on the stock in a research report on Wednesday, July 30th. Jefferies Financial Group reiterated a "hold" rating and issued a GBX 100 ($1.34) price objective on shares of Synthomer in a research report on Tuesday.

Check Out Our Latest Report on Synthomer

Insider Buying and Selling

In related news, insider Jonathan Silver acquired 59,229 shares of the business's stock in a transaction that occurred on Wednesday, August 6th. The shares were acquired at an average cost of GBX 65 ($0.87) per share, for a total transaction of £38,498.85 ($51,780.56). Also, insider Janet E. Ashdown acquired 19,920 shares of Synthomer stock in a transaction that occurred on Thursday, July 3rd. The stock was bought at an average cost of GBX 99 ($1.33) per share, with a total value of £19,720.80 ($26,524.28). Insiders acquired 99,149 shares of company stock valued at $7,101,965 in the last three months. 28.00% of the stock is currently owned by corporate insiders.

Synthomer Trading Down 2.8%

The company has a quick ratio of 0.97, a current ratio of 1.90 and a debt-to-equity ratio of 78.27. The stock has a market capitalization of £102.60 million, a P/E ratio of -1.25, a PEG ratio of -0.17 and a beta of 1.79. The firm's 50-day simple moving average is GBX 98.97 and its 200 day simple moving average is GBX 109.20.

Synthomer (LON:SYNT - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported GBX (5.40) (($0.07)) earnings per share (EPS) for the quarter. Synthomer had a negative return on equity of 7.52% and a negative net margin of 4.40%. Equities research analysts anticipate that Synthomer plc will post 12.962963 EPS for the current fiscal year.

About Synthomer

(Get Free Report)

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection – growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed on the LSE since 1971, we employ c.3,900 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia.

See Also

Should You Invest $1,000 in Synthomer Right Now?

Before you consider Synthomer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synthomer wasn't on the list.

While Synthomer currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines